Literature DB >> 30665873

Immune Checkpoint Blockade Is Associated With Durable Responses in Pulmonary Sarcomatoid Carcinoma.

Vineeth Sukrithan1, Jason Sandler2, Rasim Gucalp1, Richard Gralla3, Balázs Halmos4.   

Abstract

Entities:  

Keywords:  Checkpoint inhibitor; Immunotherapy; PD-L1; Pembrolizumab; Tumor mutational burden

Mesh：

Substances：

Year:  2018        PMID： 30665873     DOI： 10.1016/j.cllc.2018.12.013

Source DB:  PubMed          Journal:  Clin Lung Cancer        ISSN： 1525-7304            Impact factor:   4.785


× No keyword cloud information.
  7 in total

1.  Treatment of Multiple Primary Malignancies With PD-1 Inhibitor Camrelizumab: A Case Report and Brief Literature Review.

Authors:  Yuchen Wan; Zhixue Wang; Ning Yang; Fenye Liu
Journal:  Front Oncol       Date:  2022-07-05       Impact factor: 5.738

2.  Dramatic Response of Pulmonary Sarcomatoid Carcinoma to Nivolumab Combined with Anlotinib: A Case Report.

Authors:  Caibao Jin; Bin Yang
Journal:  Case Rep Oncol       Date:  2020-06-04

3.  Preoperative systemic immune-inflammation index predicts survival and recurrence in patients with resected primary pulmonary sarcomatoid carcinoma.

Authors:  Qingpeng Zeng; Jiagen Li; Nan Sun; Qi Xue; Yushun Gao; Jun Zhao; Yousheng Mao; Juwei Mu; Dali Wang; Shugeng Gao; Jie He
Journal:  Transl Lung Cancer Res       Date:  2021-01

4.  Pulmonary Pleomorphic Carcinoma Mimicking Primary Sarcoma of the Neck: A Case Report and Literature Review.

Authors:  Daishi Ogawa; Masahisa Arahata; Masato Kuriyama; Shunji Shinagawa; Gakuto Tomizawa; Yukihiro Shimizu
Journal:  Clin Interv Aging       Date:  2021-02-23       Impact factor: 4.458

5.  Characteristics and clinical outcomes of pulmonary sarcomatoid carcinoma: experience from Tata Memorial Centre.

Authors:  Suresh Kumar Bondili; Ravindra Nandhana; Aditya Dhanawat; Vanita Noronha; Amit Joshi; Vijay Maruti Patil; Nandini Menon; Rajiv Kumar Kaushal; Anuradha Choughule; Sabita S Jiwnani; Amit Janu; Kumar Prabhash
Journal:  Ecancermedicalscience       Date:  2022-08-08

6.  Survival Analysis and Prediction Model for Pulmonary Sarcomatoid Carcinoma Based on SEER Database.

Authors:  Mingjing Chen; Qiao Yang; Zihan Xu; Bangyu Luo; Feng Li; Yongxin Yu; Jianguo Sun
Journal:  Front Oncol       Date:  2021-05-31       Impact factor: 6.244

Review 7.  First-line albumin-bound paclitaxel/carboplatin plus apatinib in advanced pulmonary sarcomatoid carcinoma: A case series and review of the literature.

Authors:  Feng-Wei Kong; Wei-Min Wang; Lei Liu; Wen-Bin Wu; Xiang Wang; Miao Zhang
Journal:  Medicine (Baltimore)       Date:  2020-06-05       Impact factor: 1.817
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.